ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,717,401 | +34.9% | 1,366,547 | +74.5% | 0.28% | +34.4% |
Q2 2023 | $36,122,512 | +91.3% | 783,059 | +66.3% | 0.21% | +102.9% |
Q1 2023 | $18,886,057 | -13.4% | 470,974 | 0.0% | 0.10% | -21.4% |
Q4 2022 | $21,820,225 | +11.9% | 470,974 | 0.0% | 0.13% | +2.3% |
Q3 2022 | $19,503,000 | -30.6% | 470,974 | 0.0% | 0.13% | -19.5% |
Q2 2022 | $28,098,000 | -12.9% | 470,974 | +6.0% | 0.16% | -14.1% |
Q1 2022 | $32,276,000 | -13.6% | 444,444 | 0.0% | 0.18% | +1.6% |
Q4 2021 | $37,373,000 | -6.8% | 444,444 | 0.0% | 0.18% | +3.4% |
Q3 2021 | $40,084,000 | -5.4% | 444,444 | 0.0% | 0.18% | -5.4% |
Q2 2021 | $42,378,000 | -16.3% | 444,444 | 0.0% | 0.19% | -15.1% |
Q1 2021 | $50,604,000 | -17.7% | 444,444 | 0.0% | 0.22% | -5.6% |
Q4 2020 | $61,524,000 | +3861.6% | 444,444 | +1677.8% | 0.23% | +1557.1% |
Q2 2017 | $1,553,000 | -54.2% | 25,000 | -50.0% | 0.01% | -50.0% |
Q1 2017 | $3,389,000 | -3.6% | 50,000 | 0.0% | 0.03% | -17.6% |
Q4 2016 | $3,516,000 | -50.4% | 50,000 | -50.0% | 0.03% | -46.9% |
Q3 2016 | $7,094,000 | +30.8% | 100,000 | -9.8% | 0.06% | +12.3% |
Q2 2016 | $5,424,000 | -30.9% | 110,894 | -10.5% | 0.06% | -31.3% |
Q1 2016 | $7,844,000 | -43.6% | 123,894 | 0.0% | 0.08% | -27.8% |
Q4 2015 | $13,898,000 | +16.5% | 123,894 | 0.0% | 0.12% | +4.5% |
Q3 2015 | $11,932,000 | -5.9% | 123,894 | 0.0% | 0.11% | -0.9% |
Q2 2015 | $12,686,000 | +37.2% | 123,894 | -16.8% | 0.11% | +44.2% |
Q1 2015 | $9,245,000 | +40.5% | 148,894 | -0.7% | 0.08% | +14.9% |
Q4 2014 | $6,582,000 | -22.5% | 150,000 | 0.0% | 0.07% | -37.4% |
Q3 2014 | $8,490,000 | +89.1% | 150,000 | +50.0% | 0.11% | +94.5% |
Q2 2014 | $4,489,000 | -8.2% | 100,000 | 0.0% | 0.06% | -11.3% |
Q1 2014 | $4,889,000 | – | 100,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 441,159 | $39,788,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,100 | $9,286,000 | 2.24% |
Rock Springs Capital Management LP | 801,109 | $72,252,000 | 1.52% |
Avidity Partners Management LP | 455,000 | $41,036,000 | 0.91% |
Motley Fool Asset Management LLC | 134,357 | $12,118,000 | 0.79% |
FEDERATED HERMES, INC. | 3,987,032 | $359,590,000 | 0.68% |
EMERALD ADVISERS, LLC | 196,124 | $17,688,000 | 0.64% |
Ergoteles LLC | 128,100 | $11,553,000 | 0.42% |
Tekla Capital Management LLC | 140,726 | $12,692,000 | 0.41% |
Beck Bode, LLC | 14,990 | $1,352,000 | 0.38% |